| Name | Title | Contact Details |
|---|
In 2019 Marlowe Companies Inc. (MCI) was named by Inc. Magazine as Iowa`s Fastest Growing Company in the State of Iowa and was named the 452nd Fastest Growing Privately Company in the USA, making the coveted top 500 for the first time. MCI`s subsidiaries had previously made Inc. Magazine`s List of Fastest Growing Companies 15 times respectively. MCI is headquartered in Iowa City, IA, and has nine customer contact management centers and business processing outsourcing service delivery facilities in Iowa, Georgia, Florida, Massachusetts, New Hampshire, Nova Scotia, and South Dakota. Driving modernization through digitalization, MCI ensures clients do more for less. MCI is the holding company for a diverse lineup of tech-enabled business services operating companies. MCI organically grows, acquires and operates companies that have a synergistic products and services portfolios, including but not limited to business process outsourcing (BPO), business process management (BPM), Customer Experience (CX), Digital Experience (DXP) services, application software, and technology services to mid-market & enterprise partners. MCI now employs 2,500+ talented individuals with 150+ diverse North American client partners across the following MCI brands: GravisApps, Mass Markets, The Sydney Call Centre, OnBrand24, and Valor Intelligent Processing.
ADVAL is a Southfield, MI-based company in the Computers and Electronics sector.
Guarantee Business Systems Inc is a Saint Paul, MN-based company in the Computers and Electronics sector.
Kovo is a leader in healthcare technology & billing-as-a-service. We acquire and grow medical billing businesses and systems. Our strategy is to build accretive growth through acquisitions — leveraging Kovo`s patented patient engagement technology and proprietary OneRev medical billing platform — to optimize efficiencies for healthcare providers and their patients. Combined, Kovo subsidiaries process over $80 million annually in medical billing claims and service approximately 3.5 million patients. We`ve proven our growth model with ten successful acquisitions to date.